With a state-of-the-art patented finger cuff, Wellvii’s BP Go measures non-invasive blood pressure and pulse rate from the finger eliminating the need for the cumbersome arm cuff in the clinical and home (over-the-counter) environment.

Wellvii today announced that its innovative BP Go blood pressure monitoring technology achieved FDA clearance, marking a significant milestone in the company’s mission to transform remote patient monitoring and connected healthcare.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260818687576/en/

Wellvii BP Go

The BP Go is designed to simplify the blood pressure measurement by utilizing a convenient finger-based measurement approach, eliminating many of the challenges associated with traditional arm cuffs. The device is designed for use in home and remote-care environments, which supports Wellvii’s vision of delivering accessible, connected health monitoring beyond the clinical setting.

“This FDA clearance is a transformational milestone for Wellvii and BP Go,” said Mark Khachaturian, PhD. “It brings us one step closer to making simple, accurate, and connected blood pressure monitoring available to millions of patients worldwide.”

CLINICAL SOLUTIONS

To learn more about how Wellvii can help your healthcare organization with ambulatory screen, remote patient monitoring, virtual clinical trials, and much more, visit https://wellvii.com/clinical-solutions/.

ABOUT WELLVII™

Based in Palm Beach Gardens, Florida, Wellvii Inc. is revolutionizing the efficiency and quality of healthcare with wireless connected, non-invasive vital sign measurement technology for both the consumer wellness and clinical markets.

Follow Wellvii on Twitter, LinkedIn, Instagram, Facebook, and YouTube.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260818687576/en/